Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kunes RZ"'
Autor:
Kunes RZ; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Statistics, Columbia University, New York, NY, USA., Walle T; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Land M; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nawy T; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. peerd@mskcc.org.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. peerd@mskcc.org.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Jul; Vol. 42 (7), pp. 1084-1095. Date of Electronic Publication: 2023 Sep 21.
Autor:
Haviv D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine., Kunes RZ; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.; Department of Statistics, Columbia University., Dougherty T; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine., Burdziak C; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center., Nawy T; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center., Gilbert A; Department of Mathematics and Statistics, Yale University., Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.; Howard Hughes Medical Institute.
Publikováno v:
ArXiv [ArXiv] 2024 Jun 04. Date of Electronic Publication: 2024 Jun 04.
Autor:
Walle T; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. t.walle@dkfz.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. t.walle@dkfz.de., Bajaj S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kraske JA; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Rösner T; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Cussigh CS; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kälber KA; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller LJ; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Strobel SB; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Burghaus J; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kallenberger SM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Stein-Thöringer CK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jenzer M; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Schubert A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; BioQuant & Department of Cell and Molecular Biology, Heidelberg University, Heidelberg, Germany.; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kahle S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Williams A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Hoyler B; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zielske L; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Skatula R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Sawall S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Leber MF; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kunes RZ; Department of Statistics, Columbia University, New York, NY, USA., Krisam J; Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany., Fremd C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schneeweiss A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Krauss J; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Apostolidis L; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Berger AK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Halama N; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HITRON), Mainz, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kirsten R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hassel JC; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ungerechts G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; CanVirex, Heidelberg, Germany.; Ottawa Hospital Research Institute, Cancer Therapeutics Program, Ottawa, Ontario, Canada.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1137.
Autor:
Walle T; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.walle@dkfz.de.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. t.walle@dkfz.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. t.walle@dkfz.de., Bajaj S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kraske JA; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Rösner T; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Cussigh CS; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kälber KA; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Müller LJ; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Strobel SB; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Burghaus J; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kallenberger SM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Stein-Thöringer CK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jenzer M; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Schubert A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; BioQuant & Department of Cell and Molecular Biology, Heidelberg University, Heidelberg, Germany.; Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kahle S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Williams A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Hoyler B; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zielske L; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Skatula R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Sawall S; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Leber MF; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kunes RZ; Department of Statistics, Columbia University, New York, NY, USA., Krisam J; Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany., Fremd C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schneeweiss A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Krauss J; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Apostolidis L; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Berger AK; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Haag GM; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Halama N; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HITRON), Mainz, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kirsten R; NCT Liquid Biobank, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hassel JC; Department of Dermatology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ungerechts G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; CanVirex, Heidelberg, Germany.; Ottawa Hospital Research Institute, Cancer Therapeutics Program, Ottawa, Ontario, Canada.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1039-1051. Date of Electronic Publication: 2022 Jun 17.